A detailed history of Invesco Ltd. transactions in Mannkind Corp stock. As of the latest transaction made, Invesco Ltd. holds 1,685,128 shares of MNKD stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,685,128
Previous 1,616,237 4.26%
Holding current value
$10.3 Million
Previous $8.44 Million 25.44%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.01 - $6.7 $345,143 - $461,569
68,891 Added 4.26%
1,685,128 $10.6 Million
Q2 2024

Aug 13, 2024

SELL
$4.05 - $5.43 $1.47 Million - $1.97 Million
-363,606 Reduced 18.37%
1,616,237 $8.44 Million
Q1 2024

May 14, 2024

BUY
$3.25 - $5.27 $687,313 - $1.11 Million
211,481 Added 11.96%
1,979,843 $8.97 Million
Q4 2023

Feb 12, 2024

BUY
$3.34 - $4.29 $489,633 - $628,901
146,597 Added 9.04%
1,768,362 $6.44 Million
Q3 2023

Nov 13, 2023

BUY
$3.91 - $5.45 $98,997 - $137,988
25,319 Added 1.59%
1,621,765 $6.7 Million
Q2 2023

Aug 11, 2023

BUY
$3.72 - $4.79 $5.48 Million - $7.06 Million
1,473,036 Added 1193.61%
1,596,446 $6.5 Million
Q1 2023

May 12, 2023

SELL
$3.95 - $5.63 $2.79 Million - $3.97 Million
-706,031 Reduced 85.12%
123,410 $505,000
Q4 2022

Feb 13, 2023

BUY
$3.02 - $5.37 $2.21 Million - $3.93 Million
732,406 Added 754.79%
829,441 $4.37 Million
Q3 2022

Nov 14, 2022

SELL
$2.99 - $4.35 $30,608 - $44,530
-10,237 Reduced 9.54%
97,035 $299,000
Q2 2022

Aug 15, 2022

BUY
$2.67 - $4.77 $28,771 - $51,401
10,776 Added 11.17%
107,272 $409,000
Q1 2022

May 16, 2022

SELL
$2.62 - $4.45 $526 - $894
-201 Reduced 0.21%
96,496 $355,000
Q4 2021

Feb 14, 2022

SELL
$4.05 - $5.37 $134,006 - $177,682
-33,088 Reduced 25.49%
96,697 $423,000
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $61,730 - $86,962
15,869 Added 13.93%
129,785 $564,000
Q2 2021

Aug 17, 2021

SELL
$3.61 - $5.45 $4.81 Million - $7.26 Million
-1,332,504 Reduced 92.12%
113,916 $621,000
Q1 2021

May 17, 2021

BUY
$3.14 - $6.14 $4.42 Million - $8.64 Million
1,406,915 Added 3561.36%
1,446,420 $5.67 Million
Q4 2020

Feb 16, 2021

BUY
$1.79 - $4.04 $47,007 - $106,094
26,261 Added 198.29%
39,505 $124,000
Q3 2020

Nov 16, 2020

BUY
$1.56 - $2.08 $926 - $1,235
594 Added 4.7%
13,244 $25,000
Q1 2020

May 15, 2020

BUY
$0.84 - $1.76 $10,626 - $22,264
12,650 New
12,650 $13,000
Q1 2019

May 15, 2019

SELL
$1.14 - $2.25 $41,165 - $81,247
-36,110 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.02 - $2.05 $36,832 - $74,025
36,110 New
36,110 $38,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.